Key result
Elevated lymphocyte hydrogen sulfide production predicts coronary artery lesions in Kawasaki disease with ~85% accuracy.
Why the study?
Whether lymphocyte hydrogen sulfide production can serve as a biomarker for predicting coronary artery lesions in children with Kawasaki disease was unclear.
Does acute-phase lymphocyte hydrogen sulfide production predict coronary artery lesions at convalescence in children with Kawasaki disease?
Case-Control (n=162)
Single-blind (cardiologist performing echocardiography was blinded to clinical history)
No
Does acute-phase lymphocyte hydrogen sulfide production predict coronary artery lesions at convalescence in children with Kawasaki disease?
Acute-phase lymphocyte hydrogen sulfide production >15.285 nmol/min/10^8 lymphocytes is a promising, easily detectable biomarker for predicting coronary artery lesions in children with Kawasaki disease.
Answers are grounded in this paper and cite their sources.
Lymphocyte hydrogen sulfide production was associated with coronary lesions in Kawasaki disease; leaves open its value for risk stratification pending prospective validation.
To identify whether lymphocyte hydrogen sulfide production is a potential biomarker for predicting coronary artery lesions (CAL) in children with Kawasaki disease (KD). Eighty-six children with KD, 33 normal children and 43 children with fever from June 2016 to January 2019 in Shaanxi Provincial People's Hospital were enrolled. Of 86 KD patients, 16 patients exhibited CAL. Lymphocyte hydrogen sulfide production was significantly greater in KD patients (13.7 ± 2.7) nmol/min/108 lymphocytes than in the controls (9.26 ± 3.33) nmol/min/108 lymphocytes and the fever group (8.21 ± 2.77) nmol/min/108 lymphocytes. The lymphocyte hydrogen sulfide production was greater in CAL patients than the non-CAL patients [(16.24 ± 1.81) vs. (13.12 ± 2.58), p < 0.001]. Receiver operating characteristic curve indicated when the lymphocyte hydrogen sulfide production was >15.285 nmol/min/108 lymphocytes, the sensitivity and specificity for predicting CAL at convalescence were 87.5% and 82.9%, respectively. Lymphocyte hydrogen sulfide production in the acute period is a potentially useful biomarker for predicting CAL in KD children.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2019) conducted a case-control in Kawasaki disease and coronary artery lesions in children (n=162). Pre-treatment lymphocyte hydrogen sulfide (H2S) production vs. KD patients without coronary artery lesions (non-CAL, n=70), febrile controls (n=43), and healthy controls (n=33) was evaluated on Prediction of coronary artery lesions (CAL) at convalescence via lymphocyte hydrogen sulfide production (AUC 84.6%, 95% CI 75.1-94.2%, p=<0.001). Lymphocyte hydrogen sulfide production was higher in Kawasaki disease children with coronary artery lesions than without.
Synapse has enriched 10 related papers. Consider them for comparative context: